← All companies ← TRIP Manual TRMB → ← TNGX Pharmaceuticals TVTX →

TRLV, Trulieve Cannabis Corp.

Pharmaceuticals consumer brand UnprofitableCyclicalSerial acquirer

Trulieve Cannabis Corp. operates in highly regulated markets that require expertise in cultivation, manufacturing, and retail.

The Company's Subordinate Voting Shares (as hereinafter defined) are listed for trading on the Canadian Securities Exchange ("CSE") under the symbol "TRUL" and are also traded in the United States on the OTCQX Best Market ("OTCQX") under the symbol "TCNNF".

Headquartered in Tallahassee, Florida, we are the largest cannabis retailer in the United States with market leading retail operations in Arizona, Florida, Georgia, Pennsylvania, and West Virginia.

Latest annual: FY2025 10-K

TRLV · Trulieve Cannabis Corp.

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025

$1.2B

−0.4% YoY · 18% 5-yr CAGR

Vital signs · TTM, with 5-yr average

Revenue $1.2B 5-yr avg $1.1B

Gross margin 60% 5-yr avg 58%

Operating margin 12.5% 5-yr avg 5.4%

ROIC 7% 5-yr avg 1%

Owner-earnings margin 21% 5-yr avg 7%

Free cash flow margin 21% 5-yr avg 1%

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

Situation: Unprofitable. No sustained operating profit across the record; an earnings multiple has nothing to rest on. What the record does show is revenue, the gross-margin trajectory, and the burn against the cash on hand. Cyclical. Margins collapse and recover repeatedly across the record; a single year, good or bad, misstates the through-cycle earning power. Serial acquirer. Goodwill and acquired intangibles are 48% of assets, with meaningful acquisition spending in 4 of the record's 7 years; much of what this business is was bought, at prices the record carries.
What moves the needle: Gross margin has run about 60% and operating margin about 12% through the cycle, a wide spread between price and the cost of what it sells — whether that advantage is durable pricing power or a margin that can erode is the question the record is for. The margin is cyclical, swinging between −20% and 45% over the years, so the through-cycle figure carries more than any single year — and the balance sheet at the trough more than the peak. Inventory runs near 20% of sales, so how fast it turns back into cash — and the risk of writing it down when demand softens — sits alongside the margin. Read this kind of business on the pipeline against the patent cliff, and pricing. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.
Is it a good business?: Return on capital has rarely cleared the cost of capital (median 6%, above 15% in 2 of 6 years). By owner earnings: roughly 13% of revenue reaches owners as cash, though it swings. The cycle and the balance sheet decide this one; the worst year tells more than the median, and the rest is in the 10-K.

Every line is arithmetic on the company's filings, shown in full in the sections below.

The record

Ten years of arithmetic, read across the cycle.

The record, 2019–2025

realized figures from each filing · older years to the left

2019’19	2020’20	2021’21	2022’22	2023’23	2024’24	2025’25	TTMTTMMar 2026
								Income statement
$253M	$522M	$932M	$1.2B	$1.1B	$1.2B	$1.2B	$1.2B	RevenueRevenue
76%	74%	61%	57%	52%	60%	60%	60%	Gross marginGross mgn
6%	7%	11%	14%	34%	43%	38%	37%	SG&A / revenueSG&A/rev
$113M	$218M	$204M	$50M	($222M)	$98M	$143M	$146M	Operating incomeOp. inc.
44.8%	41.9%	21.9%	4.1%	−19.6%	8.2%	12.1%	12.5%	Operating marginOp. mgn
$53M	$63M	$17M	($253M)	($527M)	($155M)	($116M)	($81M)	Net incomeNet inc.
								Cash flow & returns
$19M	$100M	$13M	$23M	$202M	$271M	$273M	$277M	Operating cash flowOp. cash
$5M	$13M	$46M	$116M	$110M	$113M	$118M	$118M	DepreciationDeprec.
($39M)	$21M	($60M)	$141M	$608M	$294M	$251M	$220M	Working capital & otherWC & other
$72M	$100M	$276M	$165M	$40M	$123M	$44M	$37M	CapexCapex
28.4%	19.2%	29.6%	13.5%	3.6%	10.3%	3.7%	3.2%	Capex / revenueCapex/rev
$14M	$87M	($33M)	($93M)	$162M	$149M	$229M	$241M	Owner earningsOwner earn.
5.5%	16.7%	−3.5%	−7.7%	14.3%	12.5%	19.4%	20.6%	Owner earnings marginOE mgn
($53M)	($298K)	($263M)	($142M)	$162M	$149M	$229M	$241M	Free cash flowFCF
−20.9%	−0.1%	−28.2%	−11.6%	14.3%	12.5%	19.4%	20.6%	Free cash flow marginFCF mgn
$20M	$28M	$0	$28M	$0	$0	—	$0	AcquisitionsAcquis.
141%	36%	4%	—	-11%	4%	7%	7%	ROICROIC
40%	14%	1%	-13%	-37%	-12%	-10%	-7%	Return on equityROE
40%	14%	1%	−13%	−37%	−12%	−10%	−7%	Retained to equityRetained/eq
								Balance sheet
$92M	$147M	$227M	$207M	$201M	$299M	$256M	$353M	Cash & investmentsCash+inv
—	$308K	$9M	$7M	$7M	$8M	$10M	$14M	ReceivablesReceiv.
—	$98M	$212M	$277M	$213M	$231M	$242M	$242M	InventoryInvent.
—	$9M	$15M	$16M	$28M	$20M	$27M	$79M	Accounts payablePayables
—	$89M	$206M	$267M	$192M	$219M	$226M	$177M	Operating working capitalOper. WC
—	$261M	$524M	$594M	$477M	$605M	$563M	$653M	Current assetsCur. assets
—	$76M	$169M	$210M	$115M	$138M	$127M	$124M	Current liabilitiesCur. liab.
—	3.4×	3.1×	2.8×	4.2×	4.4×	4.4×	5.3×	Current ratioCurr. ratio
$7M	$67M	$765M	$791M	$484M	$484M	$484M	$484M	GoodwillGoodwill
—	$810M	$3.4B	$3.4B	$2.7B	$2.9B	$2.7B	$2.8B	Total assetsAssets
—	$6M	$463M	$542M	$363M	$365M	$137M	$198M	Total debtDebt
—	($141M)	$236M	$334M	$162M	$66M	($119M)	($155M)	Net debt / (cash)Net debt
12.5×	10.8×	7.0×	0.7×	-2.7×	1.6×	2.3×	2.4×	Interest coverageInt. cov.
$133M	$448M	$2.1B	$1.9B	$1.4B	$1.2B	$1.1B	$1.1B	Shareholders’ equityEquity
—	0.5%	1.0%	1.5%	0.9%	1.7%	1.7%	1.8%	Stock comp / revenueSBC/rev
								Per share
115M	118M	147M	188M	189M	190M	191M	198M	Shares out (diluted)Shares
$2.19	$4.41	$6.35	$6.48	$5.98	$6.24	$6.17	$5.92	Revenue / shareRev/sh
$0.46	$0.53	$0.12	$-1.34	$-2.79	$-0.82	$-0.61	$-0.41	EPS (diluted)EPS
$0.12	$0.74	$-0.22	$-0.50	$0.86	$0.78	$1.19	$1.22	Owner earnings / shareOE/sh
$-0.46	$-0.00	$-1.79	$-0.75	$0.86	$0.78	$1.19	$1.22	Free cash flow / shareFCF/sh
$0.62	$0.84	$1.88	$0.88	$0.21	$0.65	$0.23	$0.19	Cap. spending / shareCapex/sh
$1.15	$3.79	$14.63	$10.25	$7.45	$6.57	$5.97	$5.81	Book value / shareBVPS

Per-share growththe realized rate an owner's share compounded

	6-yr	5-yr
Revenue / share	+18.8%/yr	+7.0%/yr
Owner earnings / share	+46.4%/yr	+10.2%/yr
Capital spending / share	−15.2%/yr	−22.8%/yr
Book value / share	+31.6%/yr	+9.6%/yr

The record, charted

FY2019–2025

Each measure over its full record; the current point and the worst year marked.

Share count

191Mpeak FY2025

ROIC

7%low FY2023

Gross margin

60%low FY2023

Owner earnings vs. net income

Owner earningsNet income

The accountant's number, and the cash an owner can take; the gap is the tell.

$229Mowner earningsvs.($116M)net incomelow FY2022

Where the cash went

ReinvestBuybacksDividendsAcquisitionsRetainedBeyond op. cash

Each year's outlays against its operating cash: the mix, and how it drifts. The hatched cap is spending beyond that year's operating cash — financed from the balance sheet or borrowing, not operations.

FY2019FY2025

Owner-earnings bridge

FY2021–FY2025cash-flow statement, SEC EDGAR →

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business turned a $116M loss into $229M of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.

	FY2025	FY2024	FY2023	FY2022	FY2021
Reported net income	($116M)	($155M)	($527M)	($253M)	$17M
Depreciation & amortizationnon-cash charge added back	+$118M	+$113M	+$110M	+$116M	+$46M
Stock-based compensationreal costnon-cash, but a real cost	+$20M	+$20M	+$11M	+$18M	+$9M
Working capital & othertiming of cash in and out, other non-cash items	+$251M	+$294M	+$608M	+$141M	−$60M
Cash from operations	$273M	$271M	$202M	$23M	$13M
Maintenance capital expenditurethe spending needed just to hold position and volume	−$44M	−$123M	−$40M	−$116M	−$46M
Owner earnings	$229M	$149M	$162M	($93M)	($33M)
Growth capital expenditurediscretionary; spent to get bigger, not to stand still	—	—	—	−$48M	−$230M
Free cash flow	$229M	$149M	$162M	($142M)	($263M)
Owner-earnings marginowner earnings ÷ revenue	19%	13%	14%	-8%	-4%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $20M), owner earnings is nearer $208M.

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →

Will it survive?

Can it pay its interest? 2.3×

Adequate

Operating income $143M ÷ interest expense $63M

What this means
Comfortable in a normal year, but below the margin of safety Graham looked for. Worth checking how stable the coverage has been across a full cycle.
How heavy is the debt, net of cash? +$119M

Net cash

Cash $256M − debt $137M

What this means
Cash and short-term investments exceed every dollar of debt by $119M, on net the company owes nothing, and can act from strength when others can't. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.
How long is cash tied up? 171d

Long (60+ days)

DSO 3 + DIO 188 − DPO 21 days

What this means
Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash.

Is it a good business?

Return on invested capital 4%

Below average through the cycle

6-yr median, range -11%–141%; 7% latest = NOPAT $72M ÷ invested capital $1.0B

Industry peers: median 9%

What this means
The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 6 years (it ran 7% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.
Owner-earnings margin 13%

Solid through the cycle

7-yr median margin, range -8%–19%; latest $229M = operating cash $273M − maintenance capex $44M

Industry peers: median 3%

What this means
What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 19% of revenue this year, a 13% median across 7 years. Treating stock comp as the real expense it is (less $20M of SBC) leaves $208M.
Are earnings backed by cash? $273M

Loss, but cash-generative

Net income ($116M) · cash from operations $273M

In the filing’s words And the filing leans heavily on adjusted, non-GAAP earnings — steering you off the GAAP figure just where the cash is not backing it. Read the reconciliation in the notes before taking the adjusted number.

What this means
The company reported a net loss, so a conversion ratio isn't meaningful. What matters then is whether operations still threw off cash, here, they did.

How is the cash used?

Where do the earnings go? —

Not enough data

What this means
The filing data didn't include the inputs for this check.
Investing or harvesting? 0.38×

Harvesting

Capex $44M ÷ depreciation $118M

What this means
Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

Graham’s defensive tests · 2 of 6 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

Adequate size Near

Revenue ≥ $2B · $1.2B

What this means
Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.
Strong liquidity Pass

Current ratio ≥ 2× · 4.43×

What this means
Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.
Conservative debt Pass

Debt ≤ working capital · $137M vs $436M WC

What this means
Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.
Earnings stability Miss

A profit every year (7-yr record) · 4 loss years

What this means
Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.
Dividend record Miss

Uninterrupted dividends · none paid

What this means
An unbroken dividend was Graham's mark of durability. He wanted twenty years; the filings show about ten, and a single suspension breaks the streak. Non-payers, many fine modern compounders, fall outside his defensive net by design.
Earnings growth Miss

Earnings +33% over the record · −698%

What this means
At least a third more earnings than a decade ago, averaging three years at each end. Net income (not per-share), so stock splits don't distort it, buybacks and dilution show up in the share-count line instead.
Moderate price —

P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price

What this means
Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $-1.38/share (latest year $-0.61), the averaged base the calculator's gate runs on, and book value is $5.94/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2019–2025

Whether the record’s returns held, and what the capital reinvested earned.

Profitable years 3 of 7

What this means
Lost money in 4 year(s), look at what happened there before trusting the average.
Return on capital ≥ 15% 1 of 6 yrs

What this means
A moat shows up as a high return on invested capital that holds year after year, not one good vintage.
Operating margin 36% → 0% (3-yr avg ends)

What this means
Through the cycle the operating margin slipped — about 36% early to 0% lately, median 12% — competition or costs are biting in.
Reinvestment, incremental ROIC returns capital

What this means
The capital base barely grew: this business returns cash through dividends and buybacks rather than reinvesting. Judge it on the cash returned, not on compounding.
Owner earnings growth +25%/yr

What this means
Owner earnings grew about 25% a year over the record.
Worst year 2023 · −19.6% op. margin

What this means
Operations went underwater in 2023, understand why before trusting the good years.
Share count +8.8%/yr

What this means
The share count is rising, dilution works against you on a per-share basis.

Does AI threaten the moat?

Low contestability

The moat is physical, regulated or balance-sheet-funded, the kind AI cuts costs within but does not contest.

AI is unlikely to contest a moat that is physical, regulated or balance-sheet-funded; here it reads more as a cost tool than a threat.

Read from the filing's own risk factors, paired with the industry's structure under its SIC code; the durability is read above, the price below.

All figures as filed; the source filing is linked above.

Current Position

as of the latest quarter, Mar 31, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$653M

Cash & short-term investments$353M
Receivables$14M
Inventory$242M
Other current assets$44M

Current liabilities$124M

Debt due within a year$2M
Accounts payable$79M
Other current liabilities$43M

Current ratio5.26×all current assets ÷ what's due · Graham looked for 2×

Quick ratio3.31×stricter: inventory excluded

Cash ratio2.84×strictest: cash alone against what's due

Working capital$529Mthe cushion left after near-term bills

Debt due this year vs. cash$2M due · $353M cash covered by cash on hand, no refinancing forced · both figures from the Mar 31, 2026 balance sheet

Revenue, latest quarter vs. a year ago−3.7%the freshest read on whether the business is still growing

Current ratio, recent quarters5.1× → 5.3×

Deeper floors

Tangible book value($115M)equity stripped of goodwill & intangibles

Net current asset value($980M)Graham's net-net: current assets less all liabilities

Debt incl. operating leases$315M$117M of it operating leases

Deferred revenue$10Mcustomer cash collected before delivery; operating float

From the company's latest filing.

How the cash was used, 2019–2025

Over the record, the business generated $901M of operating cash; how management split it reads as a reinvestor, most operating cash is plowed back into the business.

Reinvested$819M · 91%
Retained (debt / cash)$81M · 9%

Source of fundingOperating cash
Operating cash covered reinvestment and returns; over the span cash and short-term investments rose $261M.
Net change in share count71.5%
The diluted count rose from 115M to 198M: issuance (stock pay, deals) outran any buybacks, so owners were diluted on net.
Dividend record—
No dividend line was reported in the filing data over the span; the record here neither confirms nor rules out a payout.

Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.

Acquisitions & goodwill

from the balance sheet & the 7-year cash-flow record

Goodwill grows only when a company acquires and falls only when it concedes it overpaid. The size of that bet, the cash put into buying rather than building, and how much has already been written off.

Goodwill & intangibles$1.3B48% of all assets; the premium carried on the balance sheet for businesses acquired

Against book equity42%goodwill is this share of book equity; the rest is the company’s own retained and paid-in capital

Cash spent acquiring$119Mover 7 years buying other businesses, against $819M of capital spent building

$308M written down across 1 year (2023): goodwill the company has already conceded it overpaid for, charged against earnings. A write-down costs no cash (the cash went out when the deal was signed), but it is management marking its own past judgment to market.

Goodwill, acquired intangibles and equity from the latest balance sheet; acquisition spend and write-downs summed across the 7-year record, from the company's own filings.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid.

Insider ownership3.7%
The stake all directors and executive officers hold together, per the 2026 proxy: skin in the game, the first thing Munger reads.
Stock-based compensation$20M
The slice of the business handed to employees in shares this year, 2% of revenue, equal to 14% of operating profit. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

Inverting the record

Invert: instead of why Trulieve Cannabis Corp. is a good business, the question is what would make owning it a mistake, and whether those marks are in the record. Disconfirming tests across 2019–2025.

2 of the 3 tests turned up something to look into; the other 1 came back clean.

Look hereDid the share count rise anyway?71.5%
Diluted shares grew 71.5% over 2019–2025. Owners were diluted on net; each share owns less of the business than it did. Read the buyback line beside this one, not on its own.
Look hereAre "one-time" charges a yearly habit?5 of 7 years
Management took an impairment or write-down in 5 of the last 7 years, $327M in all. Taken across the majority of the record, the "one-time" label is wearing thin — ask whether these are past deals coming due rather than genuinely isolated events. Read it beside the goodwill the company still carries.

And these came back clean

Is it less profitable than it was?

Each test is read from the filings and is noisy alone; a flag can mark a cyclical trough or a year of heavy investment as easily as a problem. The filing says which.

What an owner would ask, FY2025

read the 10-K →

Which reported numbers are a judgment call?
Management names Income taxes, Inventory as critical estimates
each rests partly on management's judgment; the filing's note sets out the assumptionsverify →

The questions the record and the charts do not answer on their own; each carries the figure and the place to look.

Peers, Pharmaceuticals

The same industry, side by side on owner economics. Each figure is a through-cycle median, so a peak or trough year can’t distort it; the group median at the foot is the line to read each against.

Company	Revenue	Gross margin	Op. margin	ROIC	Owner earn. margin
PAHCPhibro Animal Health Corporation	$1.3B	32%	8.8%	16%	3%
INDVIndivior Pharmaceuticals Inc.	$1.2B	82%	-2.9%	—	-2%
TECHBio-Techne	$1.2B	67%	21.4%	9%	22%
TRLVTrulieve Cannabis Corp.	$1.2B	60%	12.1%	6%	13%
NVAXNovavax Inc.	$1.1B	65%	-117.4%	-128%	-50%
PBHPrestige Consumer Healthcare	$1.1B	56%	29.0%	8%	21%
USNAUSANA Health Sciences	$925M	82%	12.7%	57%	10%
TLRYTilray Brands Inc. Common Stock	$821M	24%	-66.6%	-32%	-32%
Group median	—	63%	10.5%	8%	7%

The price

What a price has to assume.

What the price implies

reverse-DCF

Type today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Trulieve Cannabis Corp. has delivered.

Trulieve Cannabis Corp.’s latest year runs above its own through-cycle margin — the reported figure may flatter a peak. So the tool opens on the through-cycle base, Graham’s averaging cutting both ways; clear the toggle below to read the latest year exactly as reported.

Today’s price $

Through the cycle, Trulieve Cannabis Corp. earns about $148M on its 12.5% median owner-earnings margin. This year’s 19.4% margin runs above that; the reported figure may flatter a peak you'd be paying on. Normalize, below, values the price on that through-cycle figure rather than the latest year. It comes pre-checked here for that reason, the same rule that already normalizes a trough; clear it to price the year as filed.

Base Normalize · through-cycle ($148M) Net of stock comp (−$21M)

—

The assumptions Required return 9% Years of high growth 10 Terminal growth 2.5%

9.0% = the 4.55% 10-year Treasury (Jul 15, 2026) + 4.45 points of equity premium. The rate you require is yours to set.

Enter a price above to run it.

Implied by the price—

Owner-earnings growth · since FY2023+19%/yr

Owner-earnings yield—

P/E (3-yr earnings ’23–’25)—

P/B—

Graham’s price gate—

Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.

Against a high-grade bond: Graham’s yardstick bond yield%

Prefilled with the 10-year Treasury (4.55%, as of Jul 15, 2026). Edit it for today’s exact figure, or a AAA corporate yield.

Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.

Owner earnings $241M on 192M shares outstanding, the balance-sheet count at 2026-03-31; net cash $155M. The base opens on the through-cycle figure (the latest year sits above the record’s own median, and Graham’s averaging cuts both ways); clear Normalize to use the year as filed. Net of stock comp treats option pay as the expense it is. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.

Weigh TRLV against another business →

Cite: Owner Scorecard, "Trulieve Cannabis Corp. (TRLV), the owner's record," https://ownerscorecard.com/c/TRLV, data as of 2026-07-09.

Manual order: ← TRIP its page in the Manual TRMB →

Industry order: ← TNGX the Pharmaceuticals chapter TVTX →